ターミナルステージの口腔癌に対するプレガバリンの鎮痛効果に関する検討

書誌事項

タイトル別名
  • Efficacy of pregabalin therapy for patients with oral cancer in terminal stage

この論文をさがす

抄録

We have often experienced the uncontrollable situation for cancer pain, especially peripheral pain such as numb, burning, and tingling even if using NSAIDs and/or opioids. It is recommended for such neuropathic pain to use some adjuvant analgesics. Pregabalin was approved for treatment of peripheral neuropathic pain besides postherpetic neuralgia and diabetic peripheral neuropathy in 2010. We started to use the medicine for oral cancer patients accompanied with peripheral neuropathic pain. In this study we investigated the efficacy of pregabalin as additional therapy on each characteristics of cancer pain. We have experienced 6 cases with oral cancer in terminal stage using the medicine. In almost all cases, pain was reduced at the end of the observation period. We were able to gain a good management of peripheral pain treated with pregabalin.

収録刊行物

  • 歯科薬物療法

    歯科薬物療法 31 (3), 101-107, 2012

    日本歯科薬物療法学会

参考文献 (13)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ